Joel Greenblatt’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Joel Greenblatt's RYTM Position: Q3 2026 in Review
Joel Greenblatt reduced its Rhythm Pharmaceuticals (RYTM) stake by 7.4% in Q3 2026, selling an estimated $43.7K and leaving 5,107 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #1591.
Joel Greenblatt first reported a position in RYTM in Q3 2023 and has held it in 13 quarters since. The position peaked at $849K in Q4 2023. 334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Joel Greenblatt held 5,107 shares of Rhythm Pharmaceuticals worth $486K as of Q3 2026.
- Joel Greenblatt sold 409 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $43.7K.
- Rhythm Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1591 holding.
- Joel Greenblatt first reported a position in Rhythm Pharmaceuticals in Q3 2023 and has held it in 13 quarters since.
- Joel Greenblatt's Rhythm Pharmaceuticals position peaked at $849K in Q4 2023.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.